Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Disc Medicine Inc shares valued at $4,885,432 were purchased by Atlas Venture Opportunity Fund on Oct 08 ’25. At $67.89 per share, Atlas Venture Opportunity Fund acquired 71,961 shares.
Also, Atlas Venture Opportunity Fund purchased 18,039 shares, netting a total of over 1,249,742 in proceeds.
Before that, Bitterman Kevin had sold 2,287 shares from its account. In a trade valued at $139,576, the Director traded Disc Medicine Inc shares for $61.03 each. Upon closing the transaction, the insider’s holdings decreased to 2,287 shares, worth approximately $41.51 million.
As published in their initiating research note from Truist on July 21, 2025, Disc Medicine Inc [IRON] has been a Buy and the price target has been revised to $86. Earlier on February 27, 2025, TD Cowen initiated its rating. Their recommendation was “a Buy” for IRON stock.
Analyzing IRON Stock Performance
On last trading session, Disc Medicine Inc [NASDAQ: IRON] rose 3.52% to $70.28. The stock’s lowest price that day was $67.215, but it reached a high of $72.68 in the same session. During the last five days, there has been a surge of approximately 4.83%. Over the course of the year, Disc Medicine Inc shares have jumped approximately 40.76%. Shares of the company reached a 52-week high of $72.68 on 10/08/25 and a 52-week low of $30.82 on 04/09/25.
Support And Resistance Levels for Disc Medicine Inc (IRON)
According to the 24-hour chart, there is a support level at 67.44, which, if violated, would cause prices to drop to 64.59. In the upper region, resistance lies at 72.90. The next price resistance is at 75.52. RSI (Relative Strength Index) is 71.24 on the 14-day chart, showing overbought technical sentiment.
Is Disc Medicine Inc subject to short interest?
Stocks of Disc Medicine Inc saw a sharp steep in short interest on 2025-09-15 dropping by -0.19 million shares to 2.24 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 2.43 million shares. A decline of -8.71% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.72 of the overall float, the days-to-cover ratio (short ratio) decline to 7.72.
Which companies own the most shares of Disc Medicine Inc (IRON)?
In terms of Disc Medicine Inc share price expectations, FactSet research, analysts set an average price target of 70.5 in the next 12 months, up nearly 3.84% from the previous closing price of $67.89. Analysts anticipate Disc Medicine Inc stock to reach 112 by 2025, with the lowest price target being 43. In spite of this, 9 analysts ranked Disc Medicine Inc stock as Buy at the end of 2025. On November 05, 2024, Morgan Stanley assigned a price target of “an Overweight” to the stock and upgraded coverage with a $85.
